Position in HUMA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
-$103,161 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
12 quarters on record
Common Shares in HUMA Over Time
Shares Held
Position Value (USD)
Derivatives in HUMA
reported options exposure · as of Jun 30, 2026CallValue
$18,954
CallShares
24,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Verition Fund Management LLC holds $156,064,619 across 65 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
438,746 | $30,997,404 | |
| 2 | 159,256 | $21,138,048 | |||
| 3 | ABVX |
Abivax S.A.
|
105,791 | $14,097,708 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
184,054 | $6,859,692 | |
| 5 | SNDX |
Syndax Pharmaceuticals Inc
|
304,939 | $6,665,966 | |
| 6 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
777,738 | $4,853,085 | |
| 7 | CYTK |
Cytokinetics Inc
|
54,889 | $4,675,993 | |
| 8 | RPRX |
Royalty Pharma plc
|
75,000 | $4,205,250 |
All Filings in HUMA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,954 | 24,300 | Call | Sole | 2026-08-14 | |
| 2025-03-31 | $103,161 | 60,505 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $490,905 | 90,240 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $77,467 | 16,139 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $115,313 | 39,356 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||